About Enzymotec
Enzymotec is a Healthcare company based in Kfar Saba (Israel) founded in 1998, and was acquired by Frutarom in October 2017. It operates as a bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses. Enzymotec has raised $21 million across 3 funding rounds from investors including Frutarom, TPY Capital and Ofer-Hi Tech. Enzymotec has completed 1 acquisition, including Union Springs Healthcare. Its focus areas include Life Sciences, Nutraceuticals Tech, Nutraceutical Ingredients and Functional Food Ingredients. Its competitors include Advanced Enzyme Technologies, The DuPont Nutrition and Health, Zivo Bioscience, Kaffe Bueno and Zarbees and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Enzymotec develops and produces biofunctional ingredients to address health needs associated with the human life cycle, starting from babies up to seniors. It develops, manufactures and markets bio-functional lipid ingredients, as well as final products, based on proprietary processes and technologies. Offerings encompass two segments - Nutrition ingredients for infant formulas and dietary supplements (sold through Advanced Lipids, our joint venture with AAK) and branded lipid-based medical foods for the dietary management of medical disorders and phospholipid-based bioactive ingredients for nutritional supplements. Other nutritional ingredients include krill oil and dietary supplements targeted at improving brain health providing benefits in memory, learning abilities and concentration. Enzymotec subsidiary Vaya Pharma manufactures lipid-based products for addressing dietary issues in Attention Deficit Hyperactivity Disorder (ADHD) and Hypertriglyceridemia.
- Headquarters Kfar Saba, Israel
- Stage Acquired
- SectorsHealthcare
- Website enzymotec.com
- Social LinkedIn X Facebook
- Acquired by Frutarom (Oct 2017)
Funding Insights of Enzymotec
Enzymotec has successfully raised a total of $21M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $12.9 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21M
- Total Rounds 3
- Last Round Post-IPO — $12.9M
- First Round $11M
(Feb 2009)
- Investors Count 6
All 3 funding rounds of Enzymotec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | $12.9M | Post-IPO | – | – | |
| Jan 2012 | $10M | Series B | – | TPY Capital | – |
| Feb 2009 | $11M | Series B | – | Ofer-Hi Tech, Millennium Materials Technologies Fund |
6 investors in total: 6 institutional.
Investors in Enzymotec
Enzymotec has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Frutarom, TPY Capital and Ofer-Hi Tech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | tpycapital.com | - | |
- | – | mmtfund.com | - | |
Traditional company manufacturing flavor and fine ingredients | 1933 | frutarom.com | Haifa, Israel | |
Produces high-quality engine parts for automotive applications. | 1997 | oferhitech.com | Waimes, Belgium | |
Arancia is engaged in food ingredients and cosmetics production. | – | arancia.com.mx | Guadalajara, Mexico | |
Galam is engaged in refining natural raw materials for food and industrial applications. | 1940 | galam.co.il | Menasha, Kibbutz Maanit, Israel |
Investor details for Enzymotec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enzymotec
Enzymotec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Union Springs Healthcare.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Natural, therapeutically-validated products are developed for mainstream medicine. | ushcare.com | Fort Mitchell, United States | 2008 | Aug 2017 | •••• |
Complete acquisition details for Enzymotec
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Enzymotec
6 dated milestones of Enzymotec across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Enzymotec is founded.
- Funding First funding round of $11.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $12.9M.
- Acquisition Acquires Union Springs Healthcare.
- Exit Acquired by Frutarom.
Competitors of Enzymotec
Enzymotec has 8 listed competitors in our database, 5 of them funded. They include Advanced Enzyme Technologies, The DuPont Nutrition and Health, Zivo Bioscience, Kaffe Bueno and Zarbees, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| advancedenzymes.com | 1989 | Thane, India | – | 689 | Enzymes are manufactured for nutrition, food, feed, and textile industries. | |
| danisco.com | 1989 | Copenhagen, Denmark | $880,085 | 1,007 | Manufactures a range of health ingredients | |
| zivobioscience.com | 1983 | Keego Harbor, United States | $962,000 | 10 | Bioactive compounds from algal strain | |
| kaffebueno.com | 2016 | Copenhagen, Denmark | $8.13M | – | Coffee beans are supplied by Kaffe Bueno in multiple categories. | |
| zarbees.com | 2008 | Draper, United States | $28.28M | – | Natural cough remedies and wellness products are developed by Zarbees. | |
| interhealthusa.com | 1987 | Benicia, United States | – | 33 | Nutraceutical and specialty ingredients are researched, developed, and supplied. | |
| nexira.com | 1895 | Rouen, France | – | – | Natural ingredients are manufactured for food, health, and nutrition sectors. | |
| maolac.com | 2020 | Jerusalem, Israel | $3.2M | – | Developing antibodies and nutrients enriched preventive nutritional products. |
Detailed competitors of Enzymotec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Enzymotec
Websites that share an audience with Enzymotec (enzymotec.com).
Websites whose visitors overlap most with Enzymotec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pepscan.nl | pepscan.nl | 100% | – | – | – |
| novartis.com | 100% | 948.8K | #58,822 | View details | |
biopartners.ch | biopartners.ch | 100% | – | – | – |
synergene-biotech.com | synergene-biotech.com | 100% | – | – | – |
| morphotek.com | 100% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Enzymotec
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
10 companies that operate in the same segment as Enzymotec (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | 910 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Enzymotec
Complete news archive for Enzymotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enzymotec
Enzymotec was founded in 1998 and raised its 1st funding round 11 years after it was founded.
Enzymotec is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.
Enzymotec is a funded company, having raised a total of $21M across 3 funding rounds to date. The company's 1st funding round was a Series B of $11M, raised on Feb 2009.
Enzymotec develops and produces biofunctional ingredients to address health needs associated with the human life cycle, starting from babies up to seniors. It develops, manufactures and markets bio-functional lipid ingredients, as well as final products, based on proprietary processes and technologies. Offerings encompass two segments - Nutrition ingredients for infant formulas and dietary supplements (sold through Advanced Lipids, our joint venture with AAK) and branded lipid-based medical foods for the dietary management of medical disorders and phospholipid-based bioactive ingredients for nutritional supplements. Other nutritional ingredients include krill oil and dietary supplements targeted at improving brain health providing benefits in memory, learning abilities and concentration. Enzymotec subsidiary Vaya Pharma manufactures lipid-based products for addressing dietary issues in Attention Deficit Hyperactivity Disorder (ADHD) and Hypertriglyceridemia.
Enzymotec's top competitors include Advanced Enzyme Technologies, Zivo Bioscience and The DuPont Nutrition and Health.
Enzymotec has made 1 acquisition, including Union Springs Healthcare.
Enzymotec has 6 investors. Key investors include Frutarom, TPY Capital, Ofer-Hi Tech, Millennium Materials Technologies Fund, and Arancia.
Yes. Enzymotec was acquired by Frutarom in October 2017.